As global trends, regulations and consumer preferences evolve, strategic insights into Altria and BAT are essential for investors trying to figure out which stock is smoking hot.
Altria reported its fourth-quarter earnings today, recording a surprising increase of 9.26% for earnings and 7.58% for revenue. The stock has been trading higher on the beat. BAT’s fourth-quarter results are expected on Feb. 12.
Both Altria and British American Tobacco recognize the changing landscape of the tobacco industry, which is anticipating a decline in global smoking rates by 2025. Consequently, both companies are strategically preparing for a future where traditional tobacco usage diminishes, focusing on alternative products such as vaping and tobacco-heating systems.
Altria has been leveraging its rights to market the IQOS tobacco-heating system. It has also diversified into other “vice” industries, including investments in Anheuser-Busch and cannabis company Cronos. BAT, on the other hand, has expanded into various product categories like vaping, aiming to mitigate the impact of declining cigarette consumption.
Financial Health and Profitability
Altria demonstrates superior profitability, with higher operating and net profit margin rates over the past 12 months compared to BAT. Altria turns 42.6% of its revenue into net earnings, while BAT converts around 31%. Also, Altria maintains a more favorable debt position, with lower interest payments relative to revenue compared to BAT. Altria’s efficient debt management is a notable strength over BAT.
Source: Data and chart – Benzinga
The sustainability and attractiveness of dividends remain crucial factors for investors, given the limited growth potential in the tobacco industry. Altria’s bigger dividend becomes a compelling reason for potential investors, emphasizing the significance of consistent returns, especially when growth prospects are limited.
Looking at multiples, Altria…